Martin Bocks, MD
Watch to find out more about this University Hospitals provider.
Pediatric Interventional Cardiology
Director, Pediatric Cath Lab, UH Rainbow Babies and Children's Hospital
Program Director, Pediatric Interventional Cardiology, UH Rainbow Babies and Children's Hospital
Associate Professor, Pediatrics, CWRU School of Medicine
Martin Bocks, MD, is Director of Pediatric Interventional Cardiology at The Congenital Heart Collaborative and the division of Pediatric Cardiology at University Hospitals Rainbow Babies & Children’s Hospital. He also has a secondary appointment within University Hospitals Harrington Heart & Vascular Institute. Dr. Bocks is an Associate Professor, Pediatric Cardiology, Case Western Reserve University School of Medicine.
Dr. Bocks is board certified in Pediatric Cardiology and Internal Medicine. His special interests include transcatheter pulmonary valve implantation and endovascular therapies for congenital heart defects in children and adults. His research interests include pediatric medical device development with particular emphasis on bioresorbable technologies for cardiac catheterization procedures and developing a wireless implantable pressure monitoring system. He was named to the medical staff at UH Rainbow Babies & Children’s Hospital in 2016.
Dr. Bocks has published numerous papers in peer-reviewed medical journals and serves in a review capacity for several periodicals.
Dr. Bocks earned a Bachelor’s degree of science in Biology from University of Michigan in Ann Arbor, Mich., and his medical degree from Wayne State University School of Medicine, Detroit. As a medical student he was inducted into Alpha Omega Alpha Honor Medical Society. He completed residency in Internal Medicine-Pediatrics and fellowships in Pediatric Cardiology and Pediatric Interventional Cardiology at the University of Michigan, Ann Arbor, Mich.
He is a Fellow of the American College of Cardiology, and his other professional memberships include the American Heart Association, Society for Cardiovascular Angiography and Intervention, American Society of Artificial Internal Organs (ASAIO), and the Society for Pediatric Research.
UH Rainbow Babies and Children's Hospital
Department of Pediatrics-Cardiology
11100 Euclid Ave
UH Westlake Health Center
960 Clague Rd
Endovascular Therapies, Pediatric Cardiac Catheterization, Bioresorbable Technologies, Pediatric Medical Device Development, Congenital Heart Defects, Trans-Catheter Pulmonary Valve Implantation
American Board of Internal Medicine - Adult Congenital Heart Disease
American Board of Pediatrics - Pediatric Cardiology
Education & Training
1994, University of Michigan
Medical / Professional School(s):
2000, Wayne State University School of Medicine
2004, Internal Medicine/Pediatrics - University of Michigan Medical Center/University of Michigan Health System
2007, Pediatric Cardiology - University of Michigan Medical Center/University of Michigan Health System
2008, Pediatric Interventional Cardiology - University of Michigan Medical Center/University of Michigan Health System
Patient Satisfaction Reviews
About Our Survey
At University Hospitals, we believe in providing patients with all the information they need to make educated decisions about their health care and to choose the right doctor to meet their needs. That is why we partner with the independent patient satisfaction company Press Ganey to survey patients about their experiences at UH facilities and with UH physicians. We hold ourselves to the highest standards of care and are dedicated to creating a positive patient experience for every individual who sees a UH doctor.
There are no comments for this practitioner.
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2015, Martin Bocks, MD did not disclose any Outside Relationships with Industry.